Sentences with phrase «on diabetes treatment»

Moreover, the previous application of the BFST - related problem solving and communication training (Wysocki et al., 1997, 1999, 2000, 2001) did not only focus exclusively on diabetes treatment - related treatment adherence or management but also included general developmental issues such as managing curfews, chores and so on.

In 2015, 1 in 11 people worldwide had diabetes and 12 % global health expenditure was incurred on diabetes treatment.

Trupanion found that policyholders with obese dogs or cats spend over 10 times more on diabetes treatment than pet owners of pets at an average weight.

Sørensen displaced last year's No. 1, Jeff Bezos of Amazon (who's now No. 87 thanks to HBR's new methodology), in part because his company made the decision to focus almost exclusively on diabetes treatment, which has driven up the company's sales and stock price.

Medicare spent more than $ 15,700 per beneficiary with diabetes in 2014, but effective intervention strategies could decrease federal spending on diabetes treatment by $ 1.3 billion in the first decade, according to analysis by Avalere Health.

One analysis by Avalere Health found that effective intervention strategies could decrease federal spending on diabetes treatment by $ 1.3 billion in the first decade.

Not exact matches

Having worked closely on major diabetes treatment medications like metformin and Sanofi's flagship insulin Lantus, Chew was taken with the idea that such treatments, however innovative, don't have to be necessary by default.

Sanofi, a diabetes specialist which is now facing increased competition from rivals, has been on a mission to boost its treatment pipeline with new products for diseases that affect a wide swath of patients.

April 24 U.S. drugmaker Eli Lilly and Co reported a quarterly profit on Tuesday on higher demand for its newer treatments such as its diabetes drug Trulicity and psoriasis medicine Taltz.

Even before we discharge your child from the hospital, we go over his or her treatment plan and schedule a follow up within the next week so that we can see how everything is going, make any necessary adjustments and help your child get on the right track for diabetes management.

Diabetes UK is the leading charity for over 3.5 million people in the UK with diabetes In 2011, Diabetes UK aims to spend over # 6 million on diabetes research to investigate the causes and prevention of diabetes, to improve care and treatment of diabetes and ultimately to work towardsDiabetes UK is the leading charity for over 3.5 million people in the UK with diabetes In 2011, Diabetes UK aims to spend over # 6 million on diabetes research to investigate the causes and prevention of diabetes, to improve care and treatment of diabetes and ultimately to work towardsdiabetes In 2011, Diabetes UK aims to spend over # 6 million on diabetes research to investigate the causes and prevention of diabetes, to improve care and treatment of diabetes and ultimately to work towardsDiabetes UK aims to spend over # 6 million on diabetes research to investigate the causes and prevention of diabetes, to improve care and treatment of diabetes and ultimately to work towardsdiabetes research to investigate the causes and prevention of diabetes, to improve care and treatment of diabetes and ultimately to work towardsdiabetes, to improve care and treatment of diabetes and ultimately to work towardsdiabetes and ultimately to work towards a cure.

New York Governor Andrew Cuomo is on the verge of making medical marijuana legal in the state — a treatment that researchers are now saying may help control blood sugar and diabetes.

Access to medication and treatments Diabetes UK believes that people with diabetes should have equal access to the best diabetes care and health outcomes available on the basis of clinical need and appropriateness, not on their or the NHS's abilityDiabetes UK believes that people with diabetes should have equal access to the best diabetes care and health outcomes available on the basis of clinical need and appropriateness, not on their or the NHS's abilitydiabetes should have equal access to the best diabetes care and health outcomes available on the basis of clinical need and appropriateness, not on their or the NHS's abilitydiabetes care and health outcomes available on the basis of clinical need and appropriateness, not on their or the NHS's ability to pay.

It is unacceptable for people with diabetes to be deprived of (new) developments because of «postcode prescribing» where access to treatment depends on where the individual lives or from whom they receive their diabetes care..

In addition to our bi-monthly magazine Balance, members receive support and the latest information on diabetes care and treatments to help them live a healthy life.

«Novel type 1 diabetes treatment shown to work on human beta cells transplanted into mice.»

The pill is being developed as a treatment for such metabolic disorders as obesity and diabetes, conditions that wreak havoc on the body and shorten life span.

Treatments based on hESCs for a whole range of conditions from diabetes to heart disease are also moving towards trials, as New Scientist reported last year.

It is possible that medical advances over the past few decades in the treatment of type 2 diabetes, hypertension and high cholesterol levels have had a greater impact on people who are overweight — which increases the risk for these conditions — whereas the effect was much smaller in those of normal weight.

More than half of this economic cost (56 %, $ 10.8 billion) was on accessing diabetes treatment, including medication and hospital stays — and one half of these costs were out - of - pocket (paid for by the patients), putting a huge financial burden on people with diabetes.

«However, as immunosuppression drugs required for transplantation can have significant adverse side effects, the treatment only makes sense for people who have frequent severe hypoglycemia despite optimal diabetes management, or for those already on immunosuppressant drugs for a kidney transplant, a group being studied in another Phase 3 trial.»

«It was the first time in the history of diabetes that patients were on nothing after one treatment,» he says.

Treatments for diabetes, smoking, Alzheimer's disease and lung cancer are just a few of the potentially lifesaving cures Scientific American has chosen to highlight in this year's roundup of drugs you've never heard of, despite their potentially huge impact on global health.

To date, diabetes treatment strategies are based on patients either injecting insulin, taking medicine to make their body more sensitive to insulin, or taking other drugs to stimulate insulin secretion.

«Diabetes treatment: New strategy focuses on maintaining higher insulin levels.»

What the researchers found using this technique could have significant impact on both the understanding and treatment of obesity, diabetes and cardiovascular disease.

The South Asian population in the UK has a higher incidence of diabetes and poorer health outcomes from treatment than the general population, but studies in the past have not focused on the role of social networks or assessed beliefs about diabetes to explore self - management behaviours in this population.

Called stereotactic body radiotherapy (SBRT), the study finds patients lived, on average, six to seven months longer following treatment with minimal side - effects even when they had other severe comorbidities such as chronic obstructive pulmonary disease (COPD), heart disease and diabetes.

«Although in 2010, the International Diabetes Federation recommended surgery for diabetic patients with mild obesity if clinical treatment is not successful, few related studies on this topic have been published,» Soggia said.

We believe that this new information on the structure of the adiponectin receptors will help us understand new relationships between the structure and functions of these important receptors, which we know to be evolutionarily conserved, and hopefully will contribute to the development of new adiponectin receptor agonists that can be used for the treatment of obesity - related diseases such as type 2 diabetes.

This recommendation was based on the ability of screening to identify persons with diabetes and evidence that more - intensive blood pressure treatment was associated with reduced risk for cardiovascular events, including cardiovascular mortality, in patients with diabetes and hypertension.

Dr Daniel Martin, Senior Lecturer and Honorary Consultant, UCL Division of Surgery and Interventional Science and Director of UCL CASE Medicine, adds: «These exciting results give us a unique insight into the possible mechanism of insulin resistance in diabetes and provide some clues as to where we should be thinking about focusing further research on novel treatments for this disease.

In conjunction with IMNE, the Endocrine Society presents the Diabetes Masters Series, a highly sought, interactive regional meeting series that is in its seventh year of providing healthcare professionals with current evidence on the clinical applications of available and emerging treatment options for patients with type 2 diabetes mellitusDiabetes Masters Series, a highly sought, interactive regional meeting series that is in its seventh year of providing healthcare professionals with current evidence on the clinical applications of available and emerging treatment options for patients with type 2 diabetes mellitusdiabetes mellitus (T2DM).

But the new study firmly establishes that some of these cells endure for many decades in some Medalists — offering clues to potential treatments for preserving and even restoring the crucial cell population, says George L. King, M.D., senior author on the paper, Joslin's chief scientific officer and head of the Dianne Nunnally Hoppes Laboratory for Diabetes Complications.

The implications of these data are that maternal treatment with antioxidants may provide possible therapy against the programming effects on vascular dysfunction in pregnancy complicated by fetal hypoxia, such as during placental insufficiency, preeclampsia, gestational diabetes or high altitude pregnancy.

Dr. Kulkarni's research focuses on investigating signaling pathways impacting growth and function of pancreatic islet cells with the long - term goal of improving therapeutic approaches for the treatment of type 1 and type 2 diabetes and obesity - associated conditions.

Widely used treatments for type 2 diabetes have different effects on the hearts of men and women, even as the drugs control blood sugar equally well in both sexes, according to researchers at the School of Medicine.

Christophe Benoist, M.D., professor of Microbiology and Immunobiology at Harvard Medical School, (who spoke on behalf of Diane Mathis, Ph.D., also a professor in the same department) discussed a molecule called I - BET that, when used as a treatment in animals during pre-diabetes or in the early stages of clinical type 1 diabetes, seemed to slow the progression of the disease.

Joslin Diabetes Center investigators now are shedding light on how the success of such microbiome treatments may be affected by genetics of the individual or animal being treated.

San Diego, California, October 10, 2013 — ViaCyte, Inc. announced today that an update on the Company's progress toward a transformative stem cell - derived cell therapy for the treatment of type 1 diabetes will be presented at the 3rd Annual Regen Med Partnering Forum, part of the 2013 Stem Cell Meeting on the Mesa to be held October 14 - 16 in La Jolla, California.

These centers focus the efforts of collaborative groups of researchers on defined areas of inquiry, to accelerate progress toward the development of new treatments and vaccines to prevent and cure type 1 diabetes, cancer and infectious disease.

A passionate believer in the power of regenerative medicine to not only treat disease but also to cure it, Dr. Bosarge launched Black Beret Life Sciences, LLC in 2014, leading research for treatments based on regenerative medicine for cancer, diabetes, neurodegeneration, osteoarthritis, and other conditions related to aging.

Since its inception, Black Beret Life Sciences has led research for treatments based on regenerative medicine for cancer, diabetes, neurodegeneration, osteoarthritis, and other conditions related to aging.

Discussion themes included: - stem cell heterogeneity - stem cell fate decisions - stem cells in regeneration & development - stem cells in disease & treatment - stem cell related bioengineering & biomaterial - theoretical stem cell biology - mathematical modelling with a focus (but no restriction) on neural stem cells, hematopoietic stem cells and diabetes.

ViaCyte, a private company that has emerged as a leader in the field of regenerative medicine, is currently focused on developing a novel cell therapy for the treatment of diabetes.

This gift will support our research on the genetic basis of cancer, diabetes, Alzheimer's, and other diseases with the goal of improving diagnosis and treatment.

The American Diabetes Association's 76th Scientific Sessions — the largest annual of gathering on diabetes research, treatment and care — got underway June 10 in New Diabetes Association's 76th Scientific Sessions — the largest annual of gathering on diabetes research, treatment and care — got underway June 10 in New diabetes research, treatment and care — got underway June 10 in New Orleans.

All the projects in the lab now are focused on trying to use stem cells, or other progenitors, to find new treatments for diabetes.

SAN DIEGO, September 9, 2016 — ViaCyte, Inc., a privately - held regenerative medicine company with the first pluripotent stem cell - derived islet replacement therapy for the treatment of diabetes in clinical - stage development, today announced participation on a panel at the 2016 BioPharm ™ America — 9th Annual International Partnering Conference.

«It would be wrong to unnecessarily raise the hopes of people living with diabetes about a new treatment for the condition on the back of the evidence provided in this study.»